From: A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
PRIMARY
RECURRENCE
HER2 negative
HER2 inconclusive
HER2 positive
50
8
2
4
5
3
22
Total
56
16
26